The FDA issued Kath Chemicals a Form 483 after an inspection of its Sterling Heights, Michigan facility revealed problems with batch reviews, product testing and cleaning, among other deficiencies.
Source: Drug Industry Daily
The FDA issued Kath Chemicals a Form 483 after an inspection of its Sterling Heights, Michigan facility revealed problems with batch reviews, product testing and cleaning, among other deficiencies.
Source: Drug Industry Daily